New psychoactive substances

This procedure establishes a system for exchanging information, early warning, and assessing risks related to new psychoactive substances. It aims to improve the EU's response to emerging drug threats and protect public health.

It affects drug control agencies, law enforcement, and public health bodies across the EU. The goal is to enable quicker identification and coordinated action against potentially harmful new substances entering the market.